Logo-bi
Original Research
Sahar Rehman, Kanwal Rehman, Muhammad Sajid Hamid Akash*
Bioimpacts. 2013;3(2): 91-95. doi: 10.5681/bi.2013.023
PMCID: PMC3713875     PMID: 23878792     Scopus ID: 84881530157    
PDF
XML
Cited By:
Original Article
Raghdah S. Bawadud ORCID, Mayson H. Alkhatib* ORCID
Bioimpacts. 2023;13(2): 145-157. doi: 10.34172/bi.2023.23515
PMCID: PMC10182446     PMID: 37193079     Scopus ID: 85152114664    
Co-delivery of NE-DTX+TQ may probably inhibit the proliferation of T47D via the induction of apoptosis and autophagy pathways and impede the migration by reducing the BCSC population and downregulating TWIST-1 expression to decrease the epithelial-to-mesenchymal transition (EMT) of breast cancer cells
Original Research
Sevda Jafari ORCID, Saba Heydarian, Raymond Lai, Elnaz Mehdizadeh Aghdam, Ommoleila Molavi* ORCID
Bioimpacts. 2023;13(1): 51-61. doi: 10.34172/bi.2022.23698
PMCID: PMC9923812     PMID: 36816998     Scopus ID: 85152099837    
Evaluation of different variables on preparation of Microspheres. F9; Freeze-dried particles prepared by W/O/W emulsion method, F1; Dried particles on the tray at room temperature, F16; Freeze-dried particles prepared by S/O/O emulsion method. W/O/W; Water in oil in water, S/O/O; Solid in oil in oil.
Original Article
Mina Yousefnezhad, Soodabeh Davaran* ORCID, Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252
PMCID: PMC10329752     PMID: 37431480     Scopus ID: 85157052599    
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
Original Article
Farzaneh Bilan ORCID, Mohammad Amini, Mohammad Amin Doustvandi, Maryam Tohidast, Amir Baghbanzadeh, Seyed Samad Hosseini ORCID, Ahad Mokhtarzadeh* ORCID, Behzad Baradaran*
Bioimpacts. 2024;14(2): 27764. doi: 10.34172/bi.2023.27764
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge